4.3 Article

Partial Remission Definition: Validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish Children with New-Onset Type 1 Diabetes

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results

Mark D. Pescovitz et al.

DIABETES CARE (2014)

Article Mathematical & Computational Biology

Comparing ROC curves derived from regression models

Venkatraman E. Seshan et al.

STATISTICS IN MEDICINE (2013)

Article Endocrinology & Metabolism

New Definition for the Partial Remission Period in Children and Adolescents with Type 1 Diabetes

Henrik B. Mortensen et al.

DIABETES CARE (2009)

Article Endocrinology & Metabolism

β-Cell Mass and Type 1 Diabetes Going, Going, Gone?

Eitan Akirav et al.

DIABETES (2008)

Article Endocrinology & Metabolism

Children diagnosed with diabetes during infancy have unique clinical characteristics

Revital Nimri et al.

HORMONE RESEARCH (2007)

Article Endocrinology & Metabolism

Shorter remission period in young versus older children with diabetes mellitus type 1

A. Dost et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2007)

Article Endocrinology & Metabolism

Redefining the clinical remission period in children with type 1 diabetes

HP Chase et al.

PEDIATRIC DIABETES (2004)

Article Endocrinology & Metabolism

Temporary preservation of β-cell function by diazoxide treatment in childhood type 1 diabetes

E Örtqvist et al.

DIABETES CARE (2004)